These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10331690)

  • 1. Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics Group.
    Brassat D; Azais-Vuillemin C; Yaouanq J; Semana G; Reboul J; Cournu I; Mertens C; Edan G; Lyon-Caen O; Clanet M; Fontaine B
    Neurology; 1999 May; 52(8):1632-6. PubMed ID: 10331690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sibling disability risk at onset and during disease progression in familial multiple sclerosis.
    Wellek A; Korsukewitz C; Bach JP; Schock S; Eienbröker C; Seitz F; Spengler A; Hemmer B; Schlegel K; Oertel WH; Sommer N; Tackenberg B
    Mult Scler; 2011 Sep; 17(9):1060-6. PubMed ID: 21561958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
    Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I
    Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort study.
    Crielaard L; Kavaliunas A; Ramanujam R; Olsson T; Hillert J; Stridh P; Kockum I; Manouchehrinia A
    J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):761-767. PubMed ID: 30824631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs.
    Oturai AB; Ryder LP; Fredrikson S; Myhr KM; Celius EG; Harbo HF; Andersen O; Akesson E; Hillert J; Madsen HO; Nyland H; Spurkland A; Datta P; Svejgaard A; Sorensen PS
    Mult Scler; 2004 Feb; 10(1):5-8. PubMed ID: 14760946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial effects on the clinical course of multiple sclerosis.
    Hensiek AE; Seaman SR; Barcellos LF; Oturai A; Eraksoi M; Cocco E; Vecsei L; Stewart G; Dubois B; Bellman-Strobl J; Leone M; Andersen O; Bencsik K; Booth D; Celius EG; Harbo HF; Hauser SL; Heard R; Hillert J; Myhr KM; Marrosu MG; Oksenberg JR; Rajda C; Sawcer SJ; Sørensen PS; Zipp F; Compston DA
    Neurology; 2007 Jan; 68(5):376-83. PubMed ID: 17261686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical concordance in sibling pairs with multiple sclerosis.
    Robertson NP; Clayton D; Fraser M; Deans J; Compston DA
    Neurology; 1996 Aug; 47(2):347-52. PubMed ID: 8757003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis sibling pairs: clustered onset and familial predisposition.
    Doolittle TH; Myers RH; Lehrich JR; Birnbaum G; Sheremata W; Franklin GM; Nelson LM; Hauser SL
    Neurology; 1990 Oct; 40(10):1546-52. PubMed ID: 2215946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression.
    Baronica KB; Mlinac K; Ozretić D; Vladić A; Bognar SK
    Coll Antropol; 2011 Jan; 35 Suppl 1():11-6. PubMed ID: 21648305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
    Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
    Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HLA-DRB1 and HLA-DQB1 alleles are associated with multiple sclerosis disability progression in Slovak population.
    Čierny D; Lehotský J; Kantorová E; Sivák Š; Javor J; Kurča E; Dobrota D; Michalik J
    Neurol Res; 2018 Jul; 40(7):607-614. PubMed ID: 29619906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clinical and demographic features between affected pairs of Italian multiple sclerosis multiplex families; relation to tumour necrosis factor genomic polymorphisms.
    Trojano M; Liguori M; De Robertis F; Stella A; Guanti G; Avolio C; Livrea P
    J Neurol Sci; 1999 Jan; 162(2):194-200. PubMed ID: 10202987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis for clinical expression in multiple sclerosis.
    Barcellos LF; Oksenberg JR; Green AJ; Bucher P; Rimmler JB; Schmidt S; Garcia ME; Lincoln RR; Pericak-Vance MA; Haines JL; Hauser SL;
    Brain; 2002 Jan; 125(Pt 1):150-8. PubMed ID: 11834600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Familial multiple sclerosis in Tomsk region].
    Alifirova VM; Titova MA; Terskikh EV; Musina NF; Sjomkina AA; Gumenyuk YS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10 Pt 2):6-9. PubMed ID: 28139604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders.
    Fragomeni MO; Bichuetti DB; Oliveira EML
    Mult Scler Relat Disord; 2018 Oct; 25():138-142. PubMed ID: 30075406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
    Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
    Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis.
    Pinholt M; Frederiksen JL; Andersen PS; Christiansen M
    Mult Scler; 2005 Oct; 11(5):511-5. PubMed ID: 16193886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
    Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J;
    J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded Disability Status Scale-Based Disability and Dental-Periodontal Conditions in Patients with Multiple Sclerosis.
    Hatipoglu H; Canbaz Kabay S; Gungor Hatipoglu M; Ozden H
    Med Princ Pract; 2016; 25(1):49-55. PubMed ID: 26473494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.